Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aneudox is a neurotropic vitamin B-complex supplement developed and manufactured by P&B Pharmaceuticals. It typically consists of a combination of thiamine (vitamin B1), pyridoxine (vitamin B6), and cyanocobalamin (vitamin B12), which are essential cofactors for metabolic processes in the central and peripheral nervous systems. Thiamine is critical for carbohydrate metabolism and energy production in nerve cells; pyridoxine is involved in the biosynthesis of neurotransmitters such as serotonin and GABA; and cyanocobalamin is vital for DNA synthesis and the maintenance of the myelin sheath. Aneudox is primarily indicated for the treatment and prevention of vitamin B deficiencies and peripheral neuropathies, including those associated with diabetes, alcoholism, or drug-induced nerve damage. A variant, Aneudox Plus, includes additional neuroprotective ingredients such as alpha-lipoic acid and folic acid to enhance its therapeutic effect in nerve health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thiamine + pyridoxine + cyanocobalamin (P&B Pharmaceuticals).